90 related articles for article (PubMed ID: 22156310)
1. Potentiation of the pressor effect of oral and intravenous tyramine during administration of the selective MAO-A inhibitor moclobemide in healthy volunteers.
Wijnands S; Chang PC; Blauw GJ; van den Krogt J; Gieschke R; Schoerlin MP; van Brummelen P
J Psychopharmacol; 1989 Jan; 3(1):36-44. PubMed ID: 22156310
[TBL] [Abstract][Full Text] [Related]
2. Tyramine pharmacodynamics during combined administration of lazabemide and moclobemide.
Dingemanse J; Hussain Y; Korn A
Int J Clin Pharmacol Ther; 1996 Apr; 34(4):172-7. PubMed ID: 8861736
[TBL] [Abstract][Full Text] [Related]
3. Effect of moclobemide, a new reversible monoamine oxidase inhibitor, on absorption and pressor effect of tyramine.
Korn A; Da Prada M; Raffesberg W; Gasic S; Eichler HG
J Cardiovasc Pharmacol; 1988 Jan; 11(1):17-23. PubMed ID: 2450251
[TBL] [Abstract][Full Text] [Related]
4. Tyramine pressor effect in man: studies with moclobemide, a novel, reversible monoamine oxidase inhibitor.
Korn A; Da Prada M; Raffesberg W; Allen S; Gasic S
J Neural Transm Suppl; 1988; 26():57-71. PubMed ID: 3162952
[TBL] [Abstract][Full Text] [Related]
5. Effect of oral linezolid on the pressor response to intravenous tyramine.
Cantarini MV; Painter CJ; Gilmore EM; Bolger C; Watkins CL; Hughes AM
Br J Clin Pharmacol; 2004 Nov; 58(5):470-5. PubMed ID: 15521893
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of moclobemide, a new reversible monoamine oxidase inhibitor.
Warrington SJ; Turner P; Mant TG; Morrison P; Haywood G; Glover V; Goodwi BL; Sandler M; John-Smith PS; McClelland GR
J Psychopharmacol; 1991 Jan; 5(1):82-91. PubMed ID: 22282124
[TBL] [Abstract][Full Text] [Related]
7. Influence of food on the tyramine pressor effect during chronic moclobemide treatment of healthy volunteers.
Audebert C; Blin O; Monjanel-Mouterde S; Auquier P; Pedarriosse AM; Dingemanse J; Durand A; Cano JP
Eur J Clin Pharmacol; 1992; 43(5):507-12. PubMed ID: 1483487
[TBL] [Abstract][Full Text] [Related]
8. [Hypertensive crises with reversible inhibitors of monoamine oxidases? Results of tyramine interaction studies].
Bieck PR
Psychiatr Prax; 1989 Aug; 16 Suppl 1():25-31. PubMed ID: 2587674
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of the pressor effect of intravenously administered tyramine during moclobemide treatment.
Zimmer R; Fischbach R; Breuel HP
Acta Psychiatr Scand Suppl; 1990; 360():76-7. PubMed ID: 2248082
[TBL] [Abstract][Full Text] [Related]
10. Linezolid, a novel oxazolidinone antibiotic: assessment of monoamine oxidase inhibition using pressor response to oral tyramine.
Antal EJ; Hendershot PE; Batts DH; Sheu WP; Hopkins NK; Donaldson KM
J Clin Pharmacol; 2001 May; 41(5):552-62. PubMed ID: 11361052
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man.
Bitsios P; Langley RW; Tavernor S; Pyykkö K; Scheinin M; Szabadi E; Bradshaw CM
Br J Clin Pharmacol; 1998 Jun; 45(6):551-8. PubMed ID: 9663810
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology of moclobemide during chronic administration of high doses to healthy subjects.
Dingemanse J; Wood N; Guentert T; Oie S; Ouwerkerk M; Amrein R
Psychopharmacology (Berl); 1998 Nov; 140(2):164-72. PubMed ID: 9860107
[TBL] [Abstract][Full Text] [Related]
13. Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors.
Zimmer R
Acta Psychiatr Scand Suppl; 1990; 360():81-3. PubMed ID: 2248084
[TBL] [Abstract][Full Text] [Related]
14. Interaction of moclobemide, a new reversible monoamine oxidase inhibitor with oral tyramine.
Gieschke R; Schmid-Burgk W; Amrein R
J Neural Transm Suppl; 1988; 26():97-104. PubMed ID: 3283292
[TBL] [Abstract][Full Text] [Related]
15. Determination and comparison of the pressor effect of tyramine during long-term moclobemide and tranylcypromine treatment in healthy volunteers.
Berlin I; Zimmer R; Cournot A; Payan C; Pedarriosse AM; Puech AJ
Clin Pharmacol Ther; 1989 Sep; 46(3):344-51. PubMed ID: 2673623
[TBL] [Abstract][Full Text] [Related]
16. Hypotensive action and weak potentiation of tyramine effect by moclobemide in rats.
Da Prada M; Burkard WP
Acta Psychiatr Scand Suppl; 1990; 360():106-7. PubMed ID: 2248060
[TBL] [Abstract][Full Text] [Related]
17. Effect of a novel monoamine-oxidase inhibitor, moclobemide on the sensitivity to intravenous tyramine and norepinephrine in humans.
Cusson JR; Goldenberg E; Larochelle P
J Clin Pharmacol; 1991 May; 31(5):462-7. PubMed ID: 2050833
[TBL] [Abstract][Full Text] [Related]
18. The effect of safinamide, a novel drug for Parkinson's disease, on pressor response to oral tyramine: a randomized, double-blind, clinical trial.
Marquet A; Kupas K; Johne A; Astruc B; Patat A; Krösser S; Kovar A
Clin Pharmacol Ther; 2012 Oct; 92(4):450-7. PubMed ID: 22948897
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
20. [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].
Andreeva NI; Golovina SM; Faermark MF; Shvarts GIa; Mashkovskiĭ MD
Farmakol Toksikol; 1991; 54(2):38-40. PubMed ID: 1884793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]